Administration of amandine to patients on optimum L-dopa dosage.
D000547:Amantadine / Q000008:administration & dosage / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D011795:Surveys and Questionnaires; D013997:Time Factors
D010919:Placebos; D004295:Dihydroxyphenylalanine; D000547:Amantadine